Plans For Mandatory EU Joint Clinical Assessments Watered Down
Executive Summary
Pharma industry representatives are calling for the proposals on health technology assessment cooperation to include more flexibility on uncertainty in evidence supporting orphans and advanced therapies.
You may also be interested in...
EU Council Agrees Compromise Position On Joint Clinical Assessments
The Alliance For Regenerative Medicines is calling for advanced therapies to be given greater priority where joint clinical assessments are concerned.
EU-Wide Joint Clinical Assessments Edge Closer
Legislation that would introduce EU-wide joint clinical assessments has moved a step forward after the European Parliament adopted its version of the proposals.
Industry Welcomes Mandatory EU Joint Clinical Assessments For HTA
Draft proposals to improve EU-wide cooperation on health technology assessments, including mandatory joint clinical assessments, have won support from EFPIA, the European Federation of Pharmaceutical Industries and Associations.